These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17695548)

  • 1. Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma.
    Alo PL; Amini M; Piro F; Pizzuti L; Sebastiani V; Botti C; Murari R; Zotti G; Di Tondo U
    Anticancer Res; 2007; 27(4B):2523-7. PubMed ID: 17695548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
    Visca P; Sebastiani V; Botti C; Diodoro MG; Lasagni RP; Romagnoli F; Brenna A; De Joannon BC; Donnorso RP; Lombardi G; Alo PL
    Anticancer Res; 2004; 24(6):4169-73. PubMed ID: 15736468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
    Visca P; Sebastiani V; Pizer ES; Botti C; De Carli P; Filippi S; Monaco S; Alo PL
    Anticancer Res; 2003; 23(1A):335-9. PubMed ID: 12680233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
    Nakamura H; Horita S; Senmaru N; Miyasaka Y; Gohda T; Inoue Y; Fujita M; Meguro T; Morita T; Nagashima K
    Oncol Rep; 2002; 9(4):751-5. PubMed ID: 12066203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
    Takahiro T; Shinichi K; Toshimitsu S
    Clin Cancer Res; 2003 Jun; 9(6):2204-12. PubMed ID: 12796387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of epidermal fatty acid-binding protein and fatty acid synthase in infiltrating ductal breast carcinoma].
    Li H; Lü Q; Xue H; Dong LH; Saima N; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):381-4. PubMed ID: 18359695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of thymidine phosphorylase expression for pancreatic cancer.
    Hong SP; Shin SK; Bang S; Park SW; Chung JB; Lee WJ; Song SY
    Hepatogastroenterology; 2009; 56(93):1178-82. PubMed ID: 19760965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
    Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
    Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
    Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
    Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
    Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
    Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.